About this policy
CMS NCA document | source_status=Closed | review_type=New | public_comment_open=False | document_id=CAG-00053N
Coverage indications
Since the exclusion for hepatitis B was originated, the state-of-the-art in medicine has changed such that the outcome for these transplant patients with hepatitis B has improved significantly. The development of antiviral drugs and the long-term passive immunization have improved the outcomes by reducing the occurrence of reinfection. Recent medical literature suggests that liver transplantation improves outcomes in patients with hepatitis B. Therefore, HCFA is removing the coverage exclusion for hepatitis B. The literature to date still does not indicate that outcomes for patients with liver cancer improve with transplantation. We will continue to review literature on this topic in the future. Should the literature support removing the exclusion for liver cancer, we will do so. Until that time, the exclusion remains.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.